Agilon Health Revenue 2020-2023 | AGL
Agilon Health revenue from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Agilon Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $4,316 |
| 2022 | $2,388 |
| 2021 | $1,521 |
| 2020 | $1,218 |
| 2019 | $794 |
| Agilon Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $816 |
| 2023-09-30 | $1,216 |
| 2023-06-30 | $1,149 |
| 2023-03-31 | $1,136 |
| 2022-12-31 | $370 |
| 2022-09-30 | $695 |
| 2022-06-30 | $670 |
| 2022-03-31 | $653 |
| 2021-12-31 | $151 |
| 2021-09-30 | $459 |
| 2021-06-30 | $499 |
| 2021-03-31 | $413 |
| 2020-12-31 | $321 |
| 2020-09-30 | $313 |
| 2020-06-30 | $294 |
| 2020-03-31 | $291 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.835B | $4.316B |
| agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $117.972B | 15.31 |
| Cencora (COR) | United States | $47.529B | 18.97 |
| ICON (ICLR) | Ireland | $24.256B | 23.92 |
| DiDi Global (DIDIY) | China | $21.667B | 0.00 |
| Avantor (AVTR) | United States | $16.686B | 22.99 |
| Viatris (VTRS) | United States | $13.340B | 3.81 |
| CochLear (CHEOY) | $13.217B | 0.00 | |
| Revvity (RVTY) | United States | $12.387B | 21.57 |
| Charles River Laboratories (CRL) | United States | $11.968B | 21.82 |
| Medpace Holdings (MEDP) | United States | $11.930B | 43.36 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.918B | 0.00 |
| Natera (NTRA) | United States | $10.907B | 0.00 |
| Solventum (SOLV) | $10.687B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.887B | 51.46 |
| Bausch + Lomb (BLCO) | Canada | $4.944B | 19.01 |
| Doximity (DOCS) | United States | $4.675B | 34.81 |
| Organon (OGN) | United States | $4.548B | 4.40 |
| Progyny (PGNY) | United States | $3.209B | 53.85 |
| Surgery Partners (SGRY) | United States | $3.128B | 29.07 |
| Sotera Health (SHC) | United States | $3.083B | 15.12 |
| Life Times (LTH) | United States | $2.793B | 30.87 |
| GoodRx Holdings (GDRX) | United States | $2.575B | 130.40 |
| Premier (PINC) | United States | $2.480B | 9.08 |
| Teladoc Health (TDOC) | United States | $2.223B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.153B | 6.96 |
| BrightSpring Health Services (BTSG) | United States | $1.809B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.421B | 0.00 | |
| Agiliti (AGTI) | United States | $1.364B | 22.27 |
| NovoCure (NVCR) | Jersey | $1.341B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.926B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.750B | 7.76 |
| Embecta (EMBC) | United States | $0.596B | 3.94 |
| Auna S.A (AUNA) | Luxembourg | $0.562B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.556B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.544B | 0.00 |
| Enhabit (EHAB) | United States | $0.514B | 46.54 |
| MultiPlan (MPLN) | United States | $0.469B | 0.00 |
| Beauty Health (SKIN) | United States | $0.437B | 0.00 |
| CareDx (CDNA) | United States | $0.406B | 0.00 |
| LifeMD (LFMD) | United States | $0.400B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.366B | 0.00 |
| DocGo (DCGO) | United States | $0.340B | 54.33 |
| Sera Prognostics (SERA) | United States | $0.318B | 0.00 |
| ModivCare (MODV) | United States | $0.310B | 4.11 |
| Ascend Wellness Holdings (AAWH) | United States | $0.252B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.250B | 0.00 |
| Sharecare (SHCR) | United States | $0.240B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.114B | 38.17 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.018B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |